1351167-83-3

Basic information

• Product Name: (4-bromo-5-fluoro-2-methylphenyl)(methyl)sulfane
• Synonyms: (4-bromo-5-fluoro-2-methylphenyl)(methyl)sulfane
• CAS NO: 1351167-83-3
• Molecular Weight: 235.12
• Mol File: 1351167-83-3.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (4-bromo-5-fluoro-2-methylphenyl)(methyl)sulfane(CAS DataBase Reference)
• NIST Chemistry Reference: (4-bromo-5-fluoro-2-methylphenyl)(methyl)sulfane(1351167-83-3)
• EPA Substance Registry System: (4-bromo-5-fluoro-2-methylphenyl)(methyl)sulfane(1351167-83-3)

Safety Data

• Hazardous Substances Data: 1351167-83-3(Hazardous Substances Data)

Upstream product

• 52723-82-7 4-bromo-5-fluoro-2-methylaniline 
• 624-92-0 Dimethyldisulphide 

Downstream Products

• 1433881-01-6 (S)-3-(2-fluoro-5-methyl-4-(methylsulfonyl)phenylamino)-1-(1-(3-isopropyl-1,2,4-thiadiazol-5-yl)piperidin-4-yl)pyrrolidin-2-one 
• 1351166-10-3 (S)-1-(1-(5-ethylpyrazin-2-yl)piperidin-4-yl)-3-(2-fluoro-5-methyl-4-(methylsulfonyl)phenylamino)pyrrolidin-2-one 
• 1351166-09-0 (S)-1-(1-(5-chloropyrazin-2-yl)piperidin-4-yl)-3-(2-fluoro-5-methyl-4-(methylsulfonyl)phenylamino)pyrrolidin-2-one 
• 1351168-04-1 (S)-3-(2-fluoro-5-methyl-4-(methylsulfonyl)phenylamino)-1-(piperidin-4-yl)pyrrolidin-2-one 
• 1351168-03-0 (S)-benzyl 4-(3-(2-fluoro-5-methyl-4-(methylsulfonyl)phenylamino)-2-oxopyrrolidin-1-yl)piperidin-1-carboxylate 
• 1351166-69-2 (S)-1'-(5-ethylpyrimidin-2-yl)-3-(2-fluoro-5-methyl-4-(methylsulfonyl)phenylamino)-[1,4'-bipiperidin]-2-one 
• 1351167-82-2 1-bromo-2-fluoro-5-methyl-4-(methylsulfonyl)benzene 
• 1351166-47-6 (S)-1-(1-(5-ethylpyrimidin-2-yl)piperidin-4-yl)-3-(2-fluoro-5-methyl-4-(methylsulfonyl)phenylamino)pyrrolidin-2-one 

Relevant articles and documents

PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORS

Compounds of Formula (I) and pharmaceutically acceptable salts thereof in which X1, X2, X3, L, R3, R4, R5, R7 and n have the meanings given in the specification, are modulators of GPR119 and are useful in the treatment or prevention of diseases such as such as, but not limited to, type 2 diabetes, diabetic complications, symptoms of diabetes, metabolic syndrome, obesity, dyslipidemia, and related conditions.